U.S. Software Stock News

Wondering whether Robert Half is a bargain hiding in plain sight or a stock to steer clear of? You are definitely not alone in searching for the real value here. After a sharp slide of 61.2% over the last year and a bounce of 4.8% in the past week, the stock's movement could indicate shifting market sentiment or a signal for fresh growth potential. Robert Half has been in the headlines due to changing industry trends and recent management announcements, both of which have influenced...

Ever wondered if Sirius XM Holdings could present untapped value, or if it is just another media stock flying under the radar? Let’s dig beneath the surface to see what the numbers really say. After a slight bump of 0.9% in the last week, Sirius XM’s stock has drifted lower by 3.3% over the past month and is down 5.4% year-to-date. This has amplified questions around its potential direction and risk profile. Industry chatter recently picked up after reports that Sirius XM’s management is...

Wondering whether Plains GP Holdings is a smart buy right now? You are not alone, as investors are digging into what drives this stock’s value and if there may be hidden opportunities. Recently, shares have edged up 3.4% in the past week and climbed 4.3% over the past month, while the stock has soared an impressive 218.7% over the last five years. This has fueled the conversation around its growth trajectory. Analysts have taken note as industry headlines have pointed to stronger demand for...

Wondering if Corporación América Airports stock is the right value play for your portfolio? You are not alone. Let’s dig into what makes this company worth a closer look right now. Shares have been on the move, climbing 7.6% over the past week, up 11.4% in the last month, and an impressive 25.1% year-to-date. This caps off a 30.1% return over the last year. Behind these strong gains, investor excitement has been building around infrastructure expansion updates and renewed travel activity,...

Curious if Harley-Davidson stock is priced right for your portfolio? Let’s take a closer look at whether this iconic brand is currently undervalued or has more downside ahead. The stock has seen a 6.3% pop over the past week, but is still down 17.1% year-to-date and has lost 25.8% in the past twelve months. This raises questions about both upside potential and shifting risk perceptions. Recent headlines about Harley-Davidson's strategic investments in electric bikes and global market...

Wondering if Diamondback Energy's stock is a real bargain, or just looks that way at first glance? You're not alone, and the answer may be more interesting than you expect. The share price recently nudged up 0.4% over the past week and has climbed 3.4% in the last month. It remains down 10.5% year-to-date and 12.9% over the last twelve months, making investors wonder if the stock is turning a corner or just pausing on the way down. Market interest in Diamondback has picked up after news...

Earlier this week, Clearway Energy, Inc. announced a 1.62% increase to its quarterly dividend, following third quarter results where net income more than doubled from last year on lower tax expenses, new investments, and favorable wind conditions. This combination of higher shareholder returns, improved operational performance, and reaffirmed long-term growth objectives reflects Clearway's focus on both immediate and sustained value creation. Next, we'll explore how the company's increased...

Wondering if Jack Henry & Associates is offering real value in today’s market? Let’s cut through the noise and examine whether this stock’s price is justified or if opportunity might be knocking. Shares have picked up recently, climbing 4.9% over the past week and 11.3% in the last month. This suggests growing optimism or shifts in how investors view this company’s risk versus reward. Much of this momentum comes alongside sector headlines that point to renewed demand for financial technology...

If you have been wondering whether DaVita is undervalued or just misunderstood, you are in the right place. Let us unpack what the numbers (and the story) really say. DaVita's stock has been on a rollercoaster: up 4.3% this week, down 7.3% in the past month, and has fallen 19.8% year-to-date. It is still 62.9% higher over three years. Recent headlines have highlighted heightened attention in the kidney care sector, as mergers and evolving healthcare policies draw a spotlight to dialysis...

Wondering if Rumble’s stock price is a hidden bargain or a red flag? Let’s break it down together with a focus on what really drives value. After a sharp jump of 24.3% over the past week, Rumble shares still show a year-to-date drop of 45.5%, making it one of the more volatile names in the media space. The buzz around Rumble is largely due to its ongoing positioning as a “free speech” video platform, its continued attempts to attract high-profile creators, and recent headlines about...

Wondering if Weibo stock is a hidden bargain or a value trap? Let’s quickly unpack what’s been happening and where it might go from here. Weibo’s share price moved up 0.9% over the last week, but it’s still down 14.4% over the past month, keeping investors alert to both growth potential and risks. Recent headlines have spotlighted renewed interest in Chinese tech stocks amid regulatory shifts and fresh partnership announcements from industry players. This backdrop of evolving sentiment is...

Kura Oncology recently attracted attention after KOMZIFTI, its once-daily oral menin inhibitor, secured full FDA approval for adults with relapsed or refractory acute myeloid leukemia with a susceptible NPM1 mutation. This milestone addresses a treatment gap in AML care. See our latest analysis for Kura Oncology. Kura Oncology’s momentum has picked up meaningfully after KOMZIFTI’s approval, with the share price up over 48% in the past three months and 38% year-to-date. While recent investor...

Thinking about whether Haemonetics is a savvy investment right now? Let’s dive into what the market is signaling and where the opportunity may lie for new and existing investors. Haemonetics’ stock has seen notable swings recently, soaring 57.7% over the last month and climbing 7.4% just this past week. These moves draw attention when considering both growth and evolving risk perceptions. The recent price surge comes on the back of news highlighting the company’s expansion in innovative...

If you have ever wondered whether Hawkins is a hidden bargain or trading at a premium, you are in the right place. Let's break down what really matters when assessing value. Shareholders have seen a rollercoaster lately, with the stock jumping 5.1% over the last week but still down 22.7% in the past month. Over the long haul, Hawkins has posted a massive 442.0% return across five years. In the past few weeks, Hawkins has attracted attention thanks to industry partnerships and strategic...

Arhaus (ARHS) has attracted attention following recent trading activity, as shares saw moderate gains over the past week. Investors seem to be weighing the company's steady position in the home furnishings sector in light of broader market shifts. See our latest analysis for Arhaus. Arhaus’s recent share price jump, capped by an impressive 18% return over the last week, has caught the eye of investors. While the 1-year total shareholder return sits at a modest 3.8%, momentum appears to be...

Wondering if W. R. Berkley is trading at a bargain or getting pricey? Let’s dig into what’s really driving its value right now. The stock is on the move, climbing 1.2% over the past week and an impressive 33.8% year-to-date. This hints at renewed investor optimism or changing risk appetites. Much of this momentum has been fueled by upbeat industry-wide outlooks and W. R. Berkley’s recent moves to expand its specialty insurance offerings. These developments have caught investor attention and...

Even though Intuit Inc.'s ( NASDAQ:INTU ) recent earnings release was robust, the market didn't seem to notice. Our...

Wondering if LTC Properties is currently a good value or just another stock story? You are not alone, and understanding where it stands today could make a real difference for your portfolio. Shares have been quietly ticking upward, rising 2.1% over the past week and 7.5% so far this year. This hints at renewed interest and possibly shifting risk perceptions in the market. There has also been heightened chatter around regulatory updates and portfolio acquisitions, which are fueling optimism...

NIO (NYSE:NIO) has just posted its Q3 2025 results, reporting revenue of ¥21.8 billion and a basic EPS loss of -¥1.51. Looking back, the company has seen revenue climb from ¥17.4 billion in Q2 2024 to ¥21.8 billion this quarter, while EPS loss per share has ranged between -¥1.51 in Q3 2025 and -¥3.45 in Q4 2024. While NIO’s top-line numbers look sizable on paper, margins remain pressured and the profitability story is still playing out for investors. See our full analysis for NIO. Now, let's...

Are you wondering whether WSFS Financial is currently a bargain, or if it's time to cash in? You're definitely not alone. Valuing a stock goes beyond just looking at the price tag. WSFS Financial’s shares have climbed 4.4% over the past week and are up 8.6% year-to-date, showing renewed optimism in the company after a rocky previous 12 months. Recent news has centered on the company’s ongoing regional expansion and positive developments in its banking technology initiatives. These factors...

Ever wondered if Atlantic Union Bankshares is trading for less than what it’s really worth? If you’re curious about snapping up a value play, you’re in the right place. This stock has made some notable moves lately, rising 5.5% over the past week but still down 7.9% so far this year. This pattern points to changing market sentiment or renewed optimism after a challenging stretch. Investors recently reacted to sector-wide news about regulatory clarity and shifting interest rates. Both of...

Thinking about ICON and whether its current price offers value? You are not alone, especially if you are trying to figure out if now is an opportunity or a risk for your portfolio. ICON’s stock has made some noise recently, jumping 15.6% over the last week, which has interrupted a longer-term slide with returns of -13.6% year-to-date and -13.7% over the past year. Recent headlines highlight regulatory developments in the healthcare sector and renewed optimism around biotech funding. Both...

Wondering if Sarepta Therapeutics is finally trading at a bargain price? You are not alone, as savvy investors often watch for signs the stock might be undervalued. Sarepta’s share price has surged 27.8% in just the last week, but despite that jump, it is still down almost 85% over the past year. This volatility hints at changing risk perceptions and possible upside. Recent headlines highlight Sarepta’s FDA approval for a key gene therapy, which has revitalized sentiment and contributed...

Ever wondered if e.l.f. Beauty’s stock is actually a bargain, or just another name riding the waves of market hype? You are not alone in wanting a clear answer to whether its current price truly makes sense. The stock has shown serious movement lately, with a recent 5.6% jump over the last week. This follows a choppy 40.4% drop in the last month and a 38.8% slide year-to-date. The longer term three- and five-year returns still stand at 36.9% and an eye-catching 234.5% respectively. Investors...